A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
Clinical trial NCT07325136 · RECRUITING
Trial details
- NCT number
- NCT07325136
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-03
- Primary completion
- 2029-04-23
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.